Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Supplemental Digital Content is available in the text.

[1]  M. Link,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy. , 2017, The New England journal of medicine.

[2]  T. Edvardsen,et al.  Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.

[3]  F. Marchlinski,et al.  Ventricular tachycardia mapping and ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Lessons Learned. , 2014, World journal of cardiology.

[4]  M. Link,et al.  Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.

[5]  L. Held,et al.  Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia. , 2014, The American journal of cardiology.

[6]  L. Held,et al.  Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2014, Circulation. Cardiovascular imaging.

[7]  D. Corrado,et al.  Compound and Digenic Heterozygosity Predicts Lifetime Arrhythmic Outcome and Sudden Cardiac Death in Desmosomal Gene–Related Arrhythmogenic Right Ventricular Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.

[8]  Stefan L. Zimmerman,et al.  Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[9]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[10]  C. Semsarian,et al.  Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. , 2013, International journal of cardiology.

[11]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[12]  A. Schinkel.  Implantable Cardioverter Defibrillators in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Patient Outcomes, Incidence of Appropriate and Inappropriate Interventions, and Complications , 2013, Circulation. Arrhythmia and electrophysiology.

[13]  D. Corrado,et al.  Prognostic Value of Endocardial Voltage Mapping in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2013, Circulation. Arrhythmia and electrophysiology.

[14]  L. Held,et al.  Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. , 2013, The American journal of cardiology.

[15]  S. Russell,et al.  Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers , 2012, Circulation. Arrhythmia and electrophysiology.

[16]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[17]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[18]  P. Kirchhof,et al.  Can preload-reducing therapy prevent disease progression in arrhythmogenic right ventricular cardiomyopathy? Experimental evidence and concept for a clinical trial. , 2012, Progress in biophysics and molecular biology.

[19]  T. Lüscher,et al.  Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center , 2012, PloS one.

[20]  Dhanunjaya R. Lakkireddy,et al.  Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. , 2012, Heart rhythm.

[21]  M. Ackerman,et al.  Videoscopic Left Cardiac Sympathetic Denervation for Patients With Recurrent Ventricular Fibrillation/Malignant Ventricular Arrhythmia Syndromes Besides Congenital Long-QT Syndrome , 2012, Circulation. Arrhythmia and electrophysiology.

[22]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[23]  D. Corrado,et al.  Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance , 2012, Circulation. Arrhythmia and electrophysiology.

[24]  J. Brugada,et al.  Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique , 2012, Circulation. Arrhythmia and electrophysiology.

[25]  S. Russell,et al.  Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[26]  F. Cuoco.  Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention , 2012 .

[27]  S. Russell,et al.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. , 2011, Journal of the American College of Cardiology.

[28]  Y. Oade,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.

[29]  P. Elliott,et al.  Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.

[30]  L. Mestroni,et al.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. , 2011, European heart journal.

[31]  D. Corrado,et al.  Controversies in cardiovascular medicine Risk of sports : do we need a pre-participation screening for competitive and leisure athletes ? , 2011 .

[32]  G. Breithardt,et al.  Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. , 2011, Journal of the American College of Cardiology.

[33]  M. Link,et al.  Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia , 2010, Circulation.

[34]  C. Basso,et al.  Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2010, The American journal of cardiology.

[35]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[36]  John C Chambers,et al.  Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. , 2010, Annual review of medicine.

[37]  J. Moolman-Smook,et al.  Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. , 2009, Heart rhythm.

[38]  G. Marcus,et al.  Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.

[39]  F. Marchlinski,et al.  Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2009, Circulation.

[40]  F. Duru,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare “disease of the desmosome” with multiple clinical presentations , 2009, Clinical Research in Cardiology.

[41]  V. Barrios,et al.  Arrhythmogenic right ventricular dysplasia. , 2009, Journal of the American College of Cardiology.

[42]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[43]  A. Nogami,et al.  Changes in the Isolated Delayed Component as an Endpoint of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy: Predictor for Long‐Term Success , 2008, Journal of cardiovascular electrophysiology.

[44]  D. Corrado,et al.  Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. , 2008, Journal of the American College of Cardiology.

[45]  P. Syrris,et al.  Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[46]  S. Russell,et al.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[47]  S. Peters.  Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres , 2007, Journal of cardiovascular medicine.

[48]  A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[49]  Petros Syrris,et al.  Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[50]  G. Boriani,et al.  Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy , 2007, Heart and Vessels.

[51]  D. Pennell,et al.  Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. , 2006, Journal of the American College of Cardiology.

[52]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[53]  Maurizio Schiavon,et al.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.

[54]  A. Biederman,et al.  Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[55]  W. Shimizu,et al.  Catheter Ablation of Stable and Unstable Ventricular Tachycardias in Patients with Arrhythmogenic Right Ventricular Dysplasia , 2006, Journal of cardiovascular electrophysiology.

[56]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. , 2006, Circulation.

[57]  S. Russell,et al.  Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. , 2005, Heart rhythm.

[58]  E. Aliot,et al.  Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[59]  K. Lemola,et al.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre , 2005, Heart.

[60]  G. Danieli,et al.  Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. , 2005, European heart journal.

[61]  A. Verma,et al.  Short- and Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia , 2005, Circulation.

[62]  J. Bourke,et al.  Right ventricular disarticulation. An 18-year single centre experience. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[63]  S. Russell,et al.  Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.

[64]  A. Bassett,et al.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). , 2005, Journal of the American College of Cardiology.

[65]  S. Sen-Chowdhry,et al.  Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. , 2004, The American journal of medicine.

[66]  A. Russo,et al.  Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy , 2004, Circulation.

[67]  X. Jouven,et al.  Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Circulation.

[68]  H. Halperin,et al.  Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[69]  G. Breithardt,et al.  Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients , 2004, Circulation.

[70]  Paul J. Wang,et al.  Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators , 1997, Journal of Interventional Cardiac Electrophysiology.

[71]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[72]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[73]  G. Steinbeck,et al.  Electroanatomic Mapping of Endocardial Right Ventricular Activation as a Guide for Catheter Ablation in Patients with Arrhythmogenic Right Ventricular Dysplasia , 2003, Pacing and clinical electrophysiology : PACE.

[74]  Jeffrey A Feinstein,et al.  Electrical Resynchronization: A Novel Therapy for the Failing Right Ventricle , 2003, Circulation.

[75]  A. Carpentier,et al.  Right ventricular cardiomyoplasty: 10-year follow-up. , 2003, The Annals of thoracic surgery.

[76]  L. Jordaens,et al.  Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias , 2001, Heart.

[77]  G. Danieli,et al.  Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[78]  R. Frank,et al.  Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: A 16-year experience , 2000, Current cardiology reports.

[79]  D. Corrado,et al.  CARDIOMYOPATHY Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment , 2022 .

[80]  G. Breithardt,et al.  Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. , 2000, Circulation.

[81]  W. Stevenson,et al.  Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. , 1998, Journal of the American College of Cardiology.

[82]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[83]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[84]  H. Scheld,et al.  Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. , 1994, American heart journal.

[85]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[86]  G. Breithardt,et al.  Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.

[87]  G. Breithardt,et al.  Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.

[88]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[89]  G. Fontaine,et al.  Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. , 1989, European heart journal.

[90]  J. Gallagher,et al.  Long-term follow-up in patients with arrhythmogenic right ventricular disease. , 1989, European heart journal.

[91]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[92]  S. Olsson,et al.  A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. , 1987, British heart journal.

[93]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.